论文部分内容阅读
【正】 Guangzhou Baiyunshan Pharmaceutical Co., Ltd.(GBPC, SZ: 000522) reported on April 11th thata new drug it developed, namedcephacarboximidamide, recently received certificationfrom the United States Pharmacopeia(USP). The company has signed a cooperatio